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Hypoxia-Induced Adaptation
to Mitral Regurgitation
A Role for KATP Channel
Up-Regulation?*
Gary D. Lopaschuk, PHD, Jagdip S. Jaswal, PHD
Edmonton, Alberta, Canada
Mitral regurgitation (MR) is a common cardiac problem
that increases dramatically with age. The consequences of
MR are left ventricular volume overload, cardiac hypertro-
phy, and the eventual development of left ventricular dila-
tion and dysfunction. Compensated or decompensated MR
can result in a number of molecular changes in the myocar-
dium that may be either adaptive or maladaptive. Tissue
hypoxia is one of the manifestations that can occur in MR.
This presence of hypoxia can have significant consequences
on organ function, one of which is related to marked
changes in cardiac energy metabolism.
See page 390
From a metabolic perspective, hypertrophy secondary to
volume overload can decrease the contribution of overall
mitochondrial oxidative metabolism to cardiac adenosine
triphosphate (ATP) production while increasing the contri-
bution of glycolysis to ATP production (1–3). Part of this
switch to glycolysis probably occurs secondary to an up-
regulation of hypoxia-inducible factor–1-alpha (HIF-1), a
ranscription factor that is up-regulated in hypoxic tissue. In
ddition to metabolic genes, results from the study of
aeis-Dauvé et al. (4) in this issue of the Journal suggest
hat HIF-1 can alter the expression, at the messenger
ribonucleic acid (mRNA) level, of Kir6.2, a subunit of the
KATP channel.
KATP channels were originally described as a cardiac
arcolemmal outward K conductance, which is subject to
inhibition by the application of intracellular ATP but not
adenosine monophosphate (5). The sensitivity of these K
channels to high-energy phosphates (e.g., ATP) positions
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only cellular electrical excitability but also energy sub-
strate metabolism. Since the original description, the
molecular characteristics of the KATP channel have been
delineated in some detail. The channels are heteroctam-
ers composed of a tetrameric arrangements Kir6.x sub-
units, which form the central channel pore and contain
the inhibitory ATP binding site, surrounded by a te-
tramer of regulatory sulfonylurea receptor subunits,
which possess intrinsic ATPase activity (6,7).
KATP channels form macromolecular complexes with a
umber of metabolically relevant enzymes, including ade-
ylate kinase and creatine kinase, as well as the glycolytic
nzymes, glyceraldehyde phosphate dehydrogenase, triose
hosphate isomerase, pyruvate kinase, and lactate dehydro-
enase (8–11). Interestingly, the glycolytic enzyme phos-
hoglycerate kinase, which generates glycolytically derived
TP, binds to the cardiac sarcolemmal membrane (12,13).
yruvate kinase and phosphoglycerate kinase are the ATP-
enerating enzymes of glycolysis, and their close proximity
o the KATP channel may produce localized microdomains
of elevated cytosolic ATP concentration above the cytosolic
mean concentration. Although the regulation of KATP
channel activity by ATP and adenosine diphosphate is
complex, the channel is suggested to be preferentially
regulated by glycolytically derived ATP (14). Interestingly,
almost every glycolytic enzyme is under the transcriptional
control of HIF-1 (15). The up-regulation of HIF-1
observed in patients with mild to moderate MR may thus be
a part of an early adaptive response that contributes to the
metabolic phenotype of increased glycolysis in the setting of
cardiac hypertrophy. Such an increase in glycolytic enzymes
may also be required to ensure proper regulation of the
cardiac KATP channel, which has decreased responsiveness
to ATP in the presence of cardiac hypertrophy (15). Such
effects may allow the heart to adapt to the mild to moderate
pathology described by Raeis-Dauvé et al. (4). However, it
remains to be determined whether the increased expression
of Kir6.2 observed in the study by Raeis-Dauvé et al. (4)
results in the generation of competent KATP channels,
especially as the expression of regulatory sulfonylurea recep-
tor 2A isoform (the major sulfonylurea receptor isoform in
ventricular muscle) (16) was not assessed.
Although it is not possible to ascertain the functional
significance of increased Ki6.2 and HIF-1 expression in
he study by Raeis-Dauvé et al. (4), previous studies do
uggest that increased Kir6.2 expression may contribute to
imiting cardiac pathology. Increased cardiac hemodynamic
oad in response to transverse aortic constriction predisposes
o the development of cardiac hypertrophy and heart failure.
revious reports implicate both the pore-forming Kir6.2
ubunit and the regulatory sulfonylurea receptor 2A subunit
f KATP channels as contributing to limiting cardiac pathol-
gy. Specifically, genetic deletion of Kir6.2 leads to in-
reased mortality as well as an increased severity of heart
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Hypoxia-Induced Adaptation to MR January 24, 2012:397–9failure after transverse aortic constriction (17), while muta-
tions in ABCC9 (the gene encoding the regulatory sulfonyl-
urea 2A subunit) predispose to the development of dilated
cardiomyopathy (18). Increased sarcolemmal KATP channel
ctivity is proposed to limit cardiac pathology at least in part
y decreasing cardiac myocyte excitability and thereby
ttenuating cardiac myocyte Ca2 overload. Furthermore, a
roteomics approach has identified Kir6.2 deficiency as
emodeling the cardiac proteome such that there is in-
reased risk for susceptibility to cardiomyopathy in response
o hemodynamic stress, with the majority of proteins af-
ected being related to cardiac energy substrate metabolism
19–21). These previous findings may support the proposal
hat up-regulation of Kir6.2 is part of the cardiac adaptive or
ompensatory response in patients with mild MR and may
urther suggest that alterations in Kir6.2 expression influ-
nce that metabolic phenotype in response to hemodynamic
tress (Fig. 1). With this potential compensatory response, it
ould be interesting to characterize potential alterations in
he expression of Kir 6.2 in differing severities of MR to
elineate any contribution to disease progression and disease
tage.
The study by Raeis-Dauvé et al. (4) demonstrates several
Figure 1
Proposed Model for the Up-Regulation of Ki6.2
in Response to MR and its Contribution
to an Adaptive Cardiac Response
Mitral regurgitation (MR) can predispose to cardiac hypoxia, leading to the acti-
vation of hypoxia-inducible factor (HIF)-1-alpha (HIF-1). HIF-1 may increase
the expression of Kir6.2 by binding to a putative HIF-1 binding site in the pro-
moter region of the Kir6.2 gene. Increased Kir6.2 expression may remodel the
cardiac proteome and energy substrate metabolism, thereby allowing adapta-
tion to hemodynamic cardiac stress, as the genetic deletion of Kir6.2 predis-
poses to cardiomyopathy in response to hemodynamic stress (19–21).nteresting associative correlations in patients with mild tooderate MR. Specifically, the study defines: 1) an inverse
orrelation between the expression of left-heart Kir6.2
rotein and the venous partial pressure of oxygen; 2) a
ositive correlation between Kir6.2 mRNA and HIF-1
mRNA; and 3) associations between left ventricular
HIF-1 and Kir6.2 mRNA with cardiac hemodynamic
arameters, including systolic aortic pressure and left ven-
ricular size, as well as systolic and diastolic aortic pressures,
espectively. The study, interestingly, also identifies disso-
iation between the expression of Kir6.2 protein and Kir6.2
RNA.
As is often necessary when working with clinical biopsies,
he study was limited to samples of diseased myocardium
nd therefore lacks an ideal control group. Although this is
small observational study and can thus be subject to
chance bias,” the reported findings are nonetheless inter-
sting. However, the correlative nature of the study makes it
ifficult to establish cause-effect as well as cause-
onsequence relationships and therefore requires further
nvestigation to tailor potential therapies for this cardiac
athology. As a corollary, additional study will also be
equired to define the physiological and functional signifi-
ance of increased Kir6.2 protein expression in experimental
odels of MR. Interestingly, several previous studies have
emonstrated that Kir6.2 expression is part of the adaptive
esponse of the myocardium to pathophysiological stress
tates, including pressure overload cardiac hypertrophy.
his may suggest that the alterations in Kir6.2 expression
bserved in the study by Raeis-Dauvé et al. (4) accompany
n early adaptive metabolic response of the myocardium to
ncreased hemodynamic load secondary to MR, whereby the
eft ventricle can progress to eccentric hypertrophy to
anage increased stroke volume (i.e., forward stroke volume
nd regurgitated volume).
Although further studies are necessary, the work of
aeis-Dauvé et al. (4) does raise the intriguing possibility
hat targeting KATP channels could be an approach to
elaying surgical therapy for MR. It also raises the possi-
ility that measuring the venous partial pressure of oxygen
ay predict hypoxia and the possible up-regulation of a
ubunit of the KATP channel in MR.
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